Midtrimester n = 30 | TNL n = 68 | p-value | |
---|---|---|---|
Age | 25 (23–29.75) | 27 (23–31) | 0.302 |
Body Mass Index | 26.2 (24.1–30.3) | 28.3 (24–34) | 0.462 |
Parity: 0 | 8/30 (26.7%) | 3/68 (4.4%) | 0.003 |
≥1 | 22/30 (73.3%) | 65/68 (95.6%) | |
Race: | |||
African American | 26/30 (86.7%) | 56/68 (82.4%) | NS |
White | 1/30 (3.3%) | 5/68 (7.4%) | |
Hispanic | 2/30 (6.7%) | 2/68 (2.9%) | |
Other | 1/30 (3.3%) | 5/68 (7.4%) | |
Smoking | 4/30 (13.3%) | 13/68 (19.1%) | 0.574 |
Fetal Sex (Male) | 13/30 (43.3%) | 38/68 (55.9%) | 0.279 |
Sample GA (weeks) | 21.05 (19.9–22.6) | 39 (38.9–39.3) | < 0.001 |
Delivery GA (weeks) | 38.8 (37.9–39.6) | 39 (38.9–39.3) | 0.34 |
Sample collection | |||
Transabdominal | 30 (100%) | 4/68 (6%) | < 0.001 |
Cesarean delivery | 0 (0%) | 64/68 (94%) | |
Indication for amniocentesis | N/A | ||
Rule out Infection/ Inflammation | 20 (66.7%) | ||
Karyotyping | 12 (40%)b | ||
Fetal lung maturity | 3/67a |